The Prevalence of Fluoroquinolone Resistance Mechanisms in ColonizingEscherichia coliIsolates Recovered from Hospitalized Patients
Open Access
- 1 August 2010
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 51 (3), 280-285
- https://doi.org/10.1086/653931
Abstract
Background. Fluoroquinolones are the most commonly prescribed antimicrobials. The epidemiology of fecal colonization with Escherichia coli demonstrating reduced susceptibility to fluoroquinolones remains unclear. Methods. During a 3-year period (15 September 2004 through 19 October 2007), all patients hospitalized for >3 days were approached for fecal sampling. All E. coli isolates with reduced susceptibility to fluoroquinolones (minimum inhibitory concentration [MIC] of levofloxacin, ⩾0.125 µg/mL) were identified. We characterized gyrA and parC mutations and organic solvent tolerance. Isolates were compared using pulsed-field gel electrophoresis. Results. Of 353 patients colonized with E. coli demonstrating reduced fluoroquinolone susceptibility, 300 (85.0%) had ⩾1 gyrA mutation, 161 (45.6%) had ⩾1 parC mutation, and 171 (48.6%) demonstrated organic solvent tolerance. The mean numbers of total mutations (ie, gyrA and parC) for E. coli isolates with a levofloxacin MIC of ⩾8 µg/mL versus P < .001). Of the 136 E. coli isolates with a levofloxacin MIC of E. coli isolates demonstrating gyrA mutation, parC mutation, and organic solvent tolerance. There was little evidence of clonal spread of isolates. Conclusions. Gastrointestinal tract colonization with E. coli demonstrating reduced susceptibility to levofloxacin is common. Although 40% of study isolates exhibited a levofloxacin MIC of <8 µg/mL (and would thus be missed by current Clinical and Laboratory Standards Institute breakpoints), nalidixic acid resistance may be a useful marker for detection of such isolates. Significant temporal changes occurred in the proportion of isolates exhibiting various resistance mechanisms.Keywords
This publication has 26 references indexed in Scilit:
- Fluoroquinolone prescribing in the United States: 1995 to 2002American Journal Of Medicine, 2005
- Test Characteristics of Perirectal and Rectal Swab Compared to Stool Sample for Detection of Fluoroquinolone-Resistant Escherichia coli in the Gastrointestinal TractAntimicrobial Agents and Chemotherapy, 2005
- Longitudinal Trends in Fluoroquinolone Resistance among Enterobacteriaceae Isolates from Inpatients and Outpatients, 1989–2000: Differences in the Emergence and Epidemiology of Resistance across OrganismsClinical Infectious Diseases, 2004
- Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract InfectionsAntimicrobial Agents and Chemotherapy, 2003
- Colonization and infection with fluoroquinolone-resistantEscherichia coli among cancer patients: Clonal analysisInfection, 1998
- Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coliJournal of Antimicrobial Chemotherapy, 1998
- Molecular analysis of fluoroquinolone-resistance inEscherichia colion the aspect of gyrase and multiple antibiotic resistance (mar) genesYonsei Medical Journal, 1998
- Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coliJournal of Bacteriology, 1997
- AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutantsJournal of Bacteriology, 1996
- The Garrod lecture. Progress in understanding urinary infections.1991